Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ADH1B | P00325 | 3/20 | 0.33 |
| ▸ | ADH1A | P07327 | 3/20 | 0.33 |
| ▸ | ADH7 | P40394 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.32 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.31 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | ADH4 | P08319 | 1/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24798449 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2ADH1BADH1AADH7MEN1 | |
| SCHEMBL26902111 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2ADH1BADH1AADH7MEN1 | |
| SCHEMBL31228430 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2ADH1BADH1AADH7MEN1 | |
| SCHEMBL25696346 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2ADH1BADH1AADH7MEN1 | |
| SCHEMBL27446945 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2ADH1BADH1AADH7MEN1 | |
| SCHEMBL31697503 | 0.89 | TSHR (0.43) | SMN1; SMN2ADH1BADH1AADH7PMP22 | |
| SCHEMBL30822384 | 0.84 | EPHX2 (0.40) | SMN1; SMN2ADH1BADH1AADH7MEN1 | |
| SCHEMBL29465552 | 0.84 | CA12 (0.40) | SMN1; SMN2MEN1KMT2AEGLN1 | |
| SCHEMBL17229458 | 0.83 | SMN1; SMN2 (0.38) | SMN1; SMN2MEN1KMT2ABLMPMP22 | |
| SCHEMBL30433408 | 0.83 | SMN1; SMN2 (0.38) | SMN1; SMN2MEN1KMT2ABLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4596550-A1 | COMPOUND USABLE IN CONJUGATION REACTION AND CONJUGATE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2025-08-06 | — | — | EP | claimed |
| WO-2024114528-A9 | COMPOUND USABLE IN CONJUGATION REACTION AND CONJUGATE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-10-03 | — | — | WO | claimed |
| WO-2024114528-A1 | COMPOUND USABLE IN CONJUGATION REACTION AND CONJUGATE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-06-06 | — | — | WO | claimed |
| EP-4596550-A1 | COMPOUND USABLE IN CONJUGATION REACTION AND CONJUGATE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024233280-A1 | HETEROBIFUNCTIONAL SMALL MOLECULES THAT DEUBIQUITINYLATE AND STABILIZE TARGET PROTEINS BY RECRUITING USP7 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2024-11-14 | — | — | WO | disclosed |
| WO-2024220874-A2 | OTUB1 SMALL-MOLECULE BINDERS AND OTUB1-RECRUITING DEUBIQUITINASE-TARGETING CHIMERAS (DUBTACS) | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2024-10-24 | — | — | WO | disclosed |
| WO-2024114528-A9 | COMPOUND USABLE IN CONJUGATION REACTION AND CONJUGATE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-10-03 | — | — | WO | disclosed |
| WO-2024114528-A1 | COMPOUND USABLE IN CONJUGATION REACTION AND CONJUGATE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-06-06 | — | — | WO | disclosed |
| EP-3584576-B1 | BIS-BIOTIN AND BIS-IMINOBIOTIN DERIVATIVES AS LABELS FOR IDENTIFICATION OF POTENTIAL DRUG TARGET PROTEINS FOR DEVELOPMENT OF ANTIBODY DRUGS | MITSUI CHEMICALS INC (JP) | 2024-05-22 | — | — | EP | disclosed |
| US-11442066-B2 | Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein | MITSUI CHEMICALS, INC (JP) | 2022-09-13 | — | — | US | disclosed |
| EP-2591354-A1 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | Ardelyx, Inc. (US) | 2013-05-15 | — | — | EP | disclosed |
| EP-2590655-A1 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | Ardelyx, Inc. (US) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012006473-A1 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | ARDELYX, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
| WO-2012006475-A1 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | ARDELYX, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11442066-B2 | Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein | BTD, HLCS, STAMBP | SMN1; SMN2 4599/4885ADH1B 2080/4885ADH1A 3293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.